Copyright Reports & Markets. All rights reserved.

Global Testosterone Replacement Therapy Sales Market(Sales,Revenue and competitors Analysis of Major Market)from 2014-2026

Request for Sample of this report
Buy now

Table of Contents

    1 Executive Summary

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Testosterone Replacement Therapy Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Gels
      • 2.1.2 Injections
      • 2.1.3 Patches
      • 2.1.4 Other
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 Gels
      • 2.2.2 Injections
      • 2.2.3 Patches
      • 2.2.4 Other

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Hospitals
      • 3.1.2 Clinics
      • 3.1.3 Others

    4 Manufacturers Profiles/Analysis

    • 4.1 AbbVie
      • 4.1.1 AbbVie Profiles
      • 4.1.2 AbbVie Product Information
      • 4.1.3 AbbVie Testosterone Replacement Therapy Sales, Sales Value(Million USD), Price and Gross Profit
      • 4.1.4 AbbVie SWOT Analysis
    • 4.2 Endo International
      • 4.2.1 Endo International Profiles
      • 4.2.2 Endo International Product Information
      • 4.2.3 Endo International Testosterone Replacement TherapySales, Sales Value (Million USD), Price and Gross Profit
      • 4.2.4 Endo International SWOT Analysis
    • 4.3 Eli lilly
      • 4.3.1 Eli lilly Profiles
      • 4.3.2 Eli lilly Product Information
      • 4.3.3 Eli lilly Testosterone Replacement TherapySales, Sales Value (Million USD), Price and Gross Profit
      • 4.3.4 Eli lilly SWOT Analysis
    • 4.4 Pfizer
      • 4.4.1 Pfizer Profiles
      • 4.4.2 Pfizer Product Information
      • 4.4.3 Pfizer Testosterone Replacement TherapySales, Sales Value (Million USD), Price and Gross Profit
      • 4.4.4 Pfizer SWOT Analysis
    • 4.5 Actavis (Allergan)
      • 4.5.1 Actavis (Allergan) Profiles
      • 4.5.2 Actavis (Allergan) Product Information
      • 4.5.3 Actavis (Allergan) Testosterone Replacement TherapySales, Sales Value (Million USD), Price and Gross Profit
      • 4.5.4 Actavis (Allergan) SWOT Analysis
    • 4.6 Bayer
      • 4.6.1 Bayer Profiles
      • 4.6.2 Bayer Product Information
      • 4.6.3 Bayer Testosterone Replacement TherapySales, Sales Value (Million USD), Price and Gross Profit
      • 4.6.4 Bayer SWOT Analysis
    • 4.7 Novartis
      • 4.7.1 Novartis Profiles
      • 4.7.2 Novartis Product Information
      • 4.7.3 Novartis Testosterone Replacement TherapySales, Sales Value (Million USD), Price and Gross Profit
      • 4.7.4 Novartis SWOT Analysis
    • 4.8 Teva
      • 4.8.1 Teva Profiles
      • 4.8.2 Teva Product Information
      • 4.8.3 Teva Testosterone Replacement TherapySales, Sales Value (Million USD), Price and Gross Profit
      • 4.8.4 Teva SWOT Analysis
    • 4.9 Mylan
      • 4.9.1 Mylan Profiles
      • 4.9.2 Mylan Product Information
      • 4.9.3 Mylan Testosterone Replacement TherapySales, Sales Value (Million USD), Price and Gross Profit
      • 4.9.4 Mylan SWOT Analysis
    • 4.10 Upsher-Smith
      • 4.10.1 Upsher-Smith Profiles
      • 4.10.2 Upsher-Smith Product Information
      • 4.10.3 Upsher-Smith Testosterone Replacement TherapySales, Sales Value (Million USD), Price and Gross Profit
      • 4.10.4 Upsher-Smith SWOT Analysis
    • 4.11 Ferring Pharmaceuticals
    • 4.12 Kyowa Kirin
    • 4.13 Acerus Pharmaceuticals

    5 Market Performance for Manufacturers

    • 5.1 Global Testosterone Replacement Therapy Sales (K Units) and Market Share by Manufacturers 2014-2020
    • 5.2 Global Testosterone Replacement Therapy Revenue (M USD) and Market Share by Manufacturers 2014-2020
    • 5.3 Global Testosterone Replacement Therapy Price (USD/Unit) of Manufacturers 2014-2020
    • 5.4 Global Testosterone Replacement Therapy Gross Margin of Manufacturers 2014-2020
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 China Market Performance for Manufacturers
      • 6.1.1 China Testosterone Replacement Therapy Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.1.2 China Testosterone Replacement Therapy Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.1.3 China Testosterone Replacement Therapy Price (USD/Unit) of Manufacturers 2014-2020
      • 6.1.4 China Testosterone Replacement Therapy Gross Margin of Manufacturers 2014-2020
      • 6.1.5 Market Concentration
    • 6.2 USA Market Performance for Manufacturers
      • 6.2.1 USA Testosterone Replacement Therapy Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.2.2 USA Testosterone Replacement Therapy Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.2.3 USA Testosterone Replacement Therapy Price (USD/Unit) of Manufacturers 2014-2020
      • 6.2.4 USA Testosterone Replacement Therapy Gross Margin of Manufacturers 2014-2020
      • 6.2.5 Market Concentration
    • 6.3 Europe Market Performance for Manufacturers
      • 6.3.1 Europe Testosterone Replacement Therapy Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.3.2 Europe Testosterone Replacement Therapy Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.3.3 Europe Testosterone Replacement Therapy Price (USD/Unit) of Manufacturers 2014-2020
      • 6.3.4 Europe Testosterone Replacement Therapy Gross Margin of Manufacturers 2014-2020
      • 6.3.5 Market Concentration
    • 6.4 Japan Market Performance for Manufacturers
      • 6.4.1 Japan Testosterone Replacement Therapy Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.4.2 Japan Testosterone Replacement Therapy Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.4.3 Japan Testosterone Replacement Therapy Price (USD/Unit) of Manufacturers 2014-2020
      • 6.4.4 Japan Testosterone Replacement Therapy Gross Margin of Manufacturers 2014-2020
      • 6.4.5 Market Concentration
    • 6.5 Korea Market Performance for Manufacturers
      • 6.5.1 Korea Testosterone Replacement Therapy Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.5.2 Korea Testosterone Replacement Therapy Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.5.3 Korea Testosterone Replacement Therapy Price (USD/Unit) of Manufacturers 2014-2020
      • 6.5.4 Korea Testosterone Replacement Therapy Gross Margin of Manufacturers 2014-2020
      • 6.5.5 Market Concentration
    • 6.6 India Market Performance for Manufacturers
      • 6.6.1 India Testosterone Replacement Therapy Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.6.2 India Testosterone Replacement Therapy Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.6.3 India Testosterone Replacement Therapy Price (USD/Unit) of Manufacturers 2014-2020
      • 6.6.4 India Testosterone Replacement Therapy Gross Margin of Manufacturers 2014-2020
      • 6.6.5 Market Concentration
    • 6.7 Southeast Asia Market Performance for Manufacturers
      • 6.7.1 Southeast Asia Testosterone Replacement Therapy Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.7.2 Southeast Asia Testosterone Replacement Therapy Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.7.3 Southeast Asia Testosterone Replacement Therapy Price (USD/Unit) of Manufacturers 2014-2020
      • 6.7.4 Southeast Asia Testosterone Replacement Therapy Gross Margin of Manufacturers 2014-2020
      • 6.7.5 Market Concentration
    • 6.8 South America Market Performance for Manufacturers
      • 6.8.1 South America Testosterone Replacement Therapy Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.8.2 South America Testosterone Replacement Therapy Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.8.3 South America Testosterone Replacement Therapy Price (USD/Unit) of Manufacturers 2014-2020
      • 6.8.4 South America Testosterone Replacement Therapy Gross Margin of Manufacturers 2014-2020
      • 6.8.5 Market Concentration

    7 Global Testosterone Replacement Therapy Market Assessment by Regions (2014-2020)

    • 7.1 Global Testosterone Replacement Therapy Sales (K Units) and Market Share by Regions 2014-2020
    • 7.2 Global Testosterone Replacement Therapy Revenue (M USD) and Market Share by Regions 2014-2020
    • 7.3 Global Testosterone Replacement Therapy Price (USD/Unit) by Regions 2014-2020
    • 7.4 Global Testosterone Replacement Therapy Gross Margin by Regions 2014-2020

    8 Development Trend for Regions

    • 8.1 Global Testosterone Replacement Therapy Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.2 China Testosterone Replacement Therapy Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.3 USA Testosterone Replacement Therapy Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.4 Europe Testosterone Replacement Therapy Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.5 Japan Testosterone Replacement Therapy Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.6 Korea Testosterone Replacement Therapy Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.7 India Testosterone Replacement Therapy Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Testosterone Replacement Therapy Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Testosterone Replacement Therapy Sales and Growth, Sales Value and Growth Rate 2014-2020

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Manufacturing Plants Distribution

    11 Consumer Analysis

    • 11.1 Hospitals Industry
    • 11.2 Clinics Industry
    • 11.3 Others Industry

    12 Market Forecast 2021-2026

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
      • 12.1.1 Global Testosterone Replacement Therapy Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
      • 12.1.2 Global Testosterone Replacement Therapy Sales (K Units) and Growth Rate 2021-2026
      • 12.1.3 China Testosterone Replacement Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.4 USA Testosterone Replacement Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.5 Europe Testosterone Replacement Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.6 Japan Testosterone Replacement Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.7 Korea Testosterone Replacement Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.8 India Testosterone Replacement Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.9 Southeast Asia Testosterone Replacement Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.10 South America Testosterone Replacement Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
      • 12.2.1 Overall Market Performance
      • 12.2.2 Gels
      • 12.2.3 Injections
      • 12.2.4 Patches
      • 12.2.5 Other
    • 12.3 Sales (K Units) Forecast by Application 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 Hospitals
      • 12.3.3 Clinics
      • 12.3.4 Others
    • 12.4 Price (USD/Unit) and Gross Profit
      • 12.4.1 Global Testosterone Replacement Therapy Price (USD/Unit) Trend 2021-2026
      • 12.4.2 Global Testosterone Replacement Therapy Gross Profit Trend 2021-2026

    13 Conclusion

    In this report, in the last several years, global market of testosterone replacement therapy developed slowly, with an average growth rate of 2.11%. In 2016, global revenue of testosterone replacement therapy was nearly 1.92 billion M USD; the production was about 54.8 million units.

    Testosterone deficiency, also referred to as hypogonadism, is a common problem among men aged between 40 and 79 years, with some studies stating that nearly 30% of all men worldwide are affected by hypogonadism. As the incidence of testosterone deficiency increases, it is expected that the demand for TRT will also show a simultaneous increase.

    The classification of testosterone replacement therapy includes gels, injections, patches and other types, and the proportion of gels in 2016 was about 72%.

    Testosterone replacement therapy is widely sold in hospitals, clinics and other field. The most proportion of testosterone replacement therapy was sold in clinics, and the consumption proportion was about 43%.

    North America region was the largest supplier of testosterone replacement therapy, with a production market share nearly 86% in 2016. Europe was the second largest supplier of Testosterone Replacement Therapy, enjoying production market share nearly 9.9% in 2016.

    Market competition is intense. AbbVie, Endo International, Eli Lilly, Pfizer, Actavis (Allergan)
    Bayer, etc. are the leaders of the industry. The top five players together held about 80% of the market in the same year and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

    Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Testosterone Replacement Therapy for these regions, from 2014 to 2026 (forecast), covering
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

    Global Testosterone Replacement Therapy market competition by top manufacturers/players, with Testosterone Replacement Therapy sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
    AbbVie
    Endo International
    Eli lilly
    Pfizer
    Actavis (Allergan)
    Bayer
    Novartis
    Teva
    Mylan
    Upsher-Smith
    Ferring Pharmaceuticals
    Kyowa Kirin
    Acerus Pharmaceuticals
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Gels
    Injections
    Patches
    Other
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Testosterone Replacement Therapy for each application, including
    Hospitals
    Clinics
    Others

    If you have any special requirements, please let us know and we will offer you the report as you want.
    Buy now